Henry E. Hockeimer, Jr.

Henry E. Hockeimer, Jr.

Ballard Spahr LLP

Contact  |  View Bio  |  RSS

Latest Posts › Off-Label Use


Pharmaceutical Companies Get Off-Label Marketing Victory

Last week, a federal judge ruled that the Food and Drug Administration (FDA) cannot prohibit a pharmaceutical company from marketing its drugs for off-label uses if its claims are truthful and not misleading. This ruling,...more

8/12/2015 - Amarin Compliance FDA FDCA First Amendment Misbranding Off-Label Promotion Off-Label Use Pharmaceutical Industry

Second Circuit Reverses Conviction Involving Off-Label Promotion

A divided panel of the Second U.S. Circuit Court of Appeals has thrown out the conviction of a pharmaceutical sales representative who marketed a narcolepsy drug for so-called off-label uses not approved by the Food and Drug...more

12/5/2012 - FDCA Off-Label Use

2 Results
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.